Invesco Pharmaceuticals ETFPJP
Type
ETF
Peer group
US equity: Healthcare
Net assets
$333.1M
Expense ratio
0.57%
1-year return
+41.4%
3 years, a year
+19.2%
5 years, a year
+10.3%
12-month yield
0.89%
Holdings
34
What it aims to do.
The Invesco Pharmaceuticals ETF (the Fund) seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical Intellidex Index (the Underlying Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Invesco Private Prime Fund | 12.06% |
| PFE Pfizer Inc. | 5.21% |
| JNJ Johnson & Johnson | 4.95% |
| ABBV AbbVie Inc. | 4.90% |
| AMGN Amgen Inc. | 4.79% |
| LLY Eli Lilly and Co. | 4.76% |
| GILD Gilead Sciences, Inc. | 4.70% |
| MRK Merck & Co., Inc. | 4.67% |
| Invesco Private Government Fund | 4.64% |
| ABT Abbott Laboratories | 4.20% |
More on PJP.
- PJP overview
- PJP holdings
- PJP risk
- PJP costs
- PJP money in and out
- PJP share classes
- Compare PJP with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.